These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38315740)

  • 1. Role of the SARS-CoV-2 Virus in Brain Cells.
    Azargoonjahromi A
    Viral Immunol; 2024 Mar; 37(2):61-78. PubMed ID: 38315740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
    Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
    Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches.
    Sodagar A; Javed R; Tahir H; Razak SIA; Shakir M; Naeem M; Yusof AHA; Sagadevan S; Hazafa A; Uddin J; Khan A; Al-Harrasi A
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
    Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
    J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
    Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
    CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
    Proust A; Queval CJ; Harvey R; Adams L; Bennett M; Wilkinson RJ
    J Neuroinflammation; 2023 Aug; 20(1):184. PubMed ID: 37537664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
    Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
    Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
    Hachem M
    Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared Inflammatory Pathology of Stroke and COVID-19.
    Sánchez KE; Rosenberg GA
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurobiology of SARS-CoV-2 infection.
    Meinhardt J; Streit S; Dittmayer C; Manitius RV; Radbruch H; Heppner FL
    Nat Rev Neurosci; 2024 Jan; 25(1):30-42. PubMed ID: 38049610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation at the crossroads of COVID-19, cognitive deficits and depression.
    Lyra E Silva NM; Barros-Aragão FGQ; De Felice FG; Ferreira ST
    Neuropharmacology; 2022 May; 209():109023. PubMed ID: 35257690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.
    Alquisiras-Burgos I; Peralta-Arrieta I; Alonso-Palomares LA; Zacapala-Gómez AE; Salmerón-Bárcenas EG; Aguilera P
    Mol Neurobiol; 2021 Feb; 58(2):520-535. PubMed ID: 32978729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier function in response to SARS-CoV-2 and its spike protein.
    Suprewicz Ł; Fiedoruk K; Czarnowska A; Sadowski M; Strzelecka A; Galie PA; Janmey PA; Kułakowska A; Bucki R
    Neurol Neurochir Pol; 2023; 57(1):14-25. PubMed ID: 36810757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection.
    Welcome MO; Mastorakis NE
    Inflammopharmacology; 2021 Aug; 29(4):939-963. PubMed ID: 33822324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
    Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
    Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms.
    Haidar MA; Jourdi H; Haj Hassan Z; Ashekyan O; Fardoun M; Wehbe Z; Maaliki D; Wehbe M; Mondello S; Abdelhady S; Shahjouei S; Bizri M; Mechref Y; Gold MS; Dbaibo G; Zaraket H; Eid AH; Kobeissy F
    Neuroscientist; 2022 Dec; 28(6):552-571. PubMed ID: 33393420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.